24 April 2020
The Global Fund joins global health partners in a landmark collaboration to accelerate the development, production and equitable global access to safe, quality, effective, and affordable COVID-19 diagnostics, therapeutics and vaccines, and thus ensure that in the fight against COVID-19, no one is left behind.
We must simultaneously and urgently accelerate the strengthening of sustainable systems for health and capacities to enable delivery of the new COVID-19 tools to those who need them and to mitigate the knock-on impact on other diseases such as HIV, tuberculosis and malaria.
The world is facing an unprecedented global health emergency, but we have proven that when the world unites, we can drive the deadliest infectious diseases into retreat. Now is the time to work together in unprecedented and inclusive partnership with all stakeholders – governments, public and private sector partners, global health organizations, civil society, academia, communities and all other stakeholders across society – jointly leveraging our comparative strengths and respective voices to drive towards collective solutions, an accelerated path, and access for all. We are stronger, faster and more effective working together.
In collaboration with the Bill & Melinda Gates Foundation, CEPI, Gavi, the Vaccine Alliance, Unitaid, Wellcome Trust, the World Bank and the World Health Organization, the Global Fund joins in a commitment to unite to fight.